Annual CFF
$103.79 M
+$103.60 M+54815.87%
December 31, 2023
Summary
- As of February 8, 2025, LXEO annual cash flow from financing activities is $103.79 million, with the most recent change of +$103.60 million (+54815.87%) on December 31, 2023.
- During the last 3 years, LXEO annual CFF has risen by +$71.41 million (+220.55%).
- LXEO annual CFF is now -31.20% below its all-time high of $150.86 million, reached on December 31, 2021.
Performance
LXEO Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
-$72.00 K
-$363.00 K-124.74%
September 30, 2024
Summary
- As of February 8, 2025, LXEO quarterly cash flow from financing activities is -$72.00 thousand, with the most recent change of -$363.00 thousand (-124.74%) on September 30, 2024.
- Over the past year, LXEO quarterly CFF has dropped by -$3.98 million (-101.84%).
- LXEO quarterly CFF is now -100.07% below its all-time high of $100.07 million, reached on December 31, 2023.
Performance
LXEO Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$188.94 M
-$3.98 M-2.07%
September 30, 2024
Summary
- As of February 8, 2025, LXEO TTM cash flow from financing activities is $188.94 million, with the most recent change of -$3.98 million (-2.07%) on September 30, 2024.
- Over the past year, LXEO TTM CFF has increased by +$185.22 million (+4979.14%).
- LXEO TTM CFF is now -2.07% below its all-time high of $192.93 million, reached on June 30, 2024.
Performance
LXEO TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
LXEO Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10000.0% | -101.8% | +4979.1% |
| 3 y3 years | +220.6% | -101.8% | +4979.1% |
| 5 y5 years | +220.6% | -101.8% | +4979.1% |
LXEO Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -31.2% | >+9999.0% | -100.1% | +26.5% | -2.1% | >+9999.0% |
| 5 y | 5-year | -31.2% | >+9999.0% | -100.1% | +26.5% | -2.1% | >+9999.0% |
| alltime | all time | -31.2% | >+9999.0% | -100.1% | +26.5% | -2.1% | >+9999.0% |
Lexeo Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$72.00 K(-124.7%) | $188.94 M(-2.1%) |
| Jun 2024 | - | $291.00 K(-99.7%) | $192.93 M(+0.2%) |
| Mar 2024 | - | $88.65 M(-11.4%) | $192.54 M(+85.5%) |
| Dec 2023 | $103.79 M | $100.07 M(+2458.1%) | $103.79 M(+2690.1%) |
| Sep 2023 | - | $3.91 M(-4261.7%) | $3.72 M(+4669.2%) |
| Jun 2023 | - | -$94.00 K(-4.1%) | $78.00 K(-83.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$98.00 K(-136.3%) | $477.00 K(-17.0%) |
| Dec 2022 | $189.00 K(-99.9%) | - | - |
| Sep 2022 | - | $270.00 K(-11.5%) | $575.00 K(+88.5%) |
| Jun 2022 | - | $305.00 K | $305.00 K |
| Dec 2021 | $150.86 M(+365.9%) | - | - |
| Dec 2020 | $32.38 M | - | - |
FAQ
- What is Lexeo Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Lexeo Therapeutics?
- What is Lexeo Therapeutics annual CFF year-on-year change?
- What is Lexeo Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Lexeo Therapeutics?
- What is Lexeo Therapeutics quarterly CFF year-on-year change?
- What is Lexeo Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Lexeo Therapeutics?
- What is Lexeo Therapeutics TTM CFF year-on-year change?
What is Lexeo Therapeutics annual cash flow from financing activities?
The current annual CFF of LXEO is $103.79 M
What is the all time high annual CFF for Lexeo Therapeutics?
Lexeo Therapeutics all-time high annual cash flow from financing activities is $150.86 M
What is Lexeo Therapeutics annual CFF year-on-year change?
Over the past year, LXEO annual cash flow from financing activities has changed by +$103.60 M (+54815.87%)
What is Lexeo Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of LXEO is -$72.00 K
What is the all time high quarterly CFF for Lexeo Therapeutics?
Lexeo Therapeutics all-time high quarterly cash flow from financing activities is $100.07 M
What is Lexeo Therapeutics quarterly CFF year-on-year change?
Over the past year, LXEO quarterly cash flow from financing activities has changed by -$3.98 M (-101.84%)
What is Lexeo Therapeutics TTM cash flow from financing activities?
The current TTM CFF of LXEO is $188.94 M
What is the all time high TTM CFF for Lexeo Therapeutics?
Lexeo Therapeutics all-time high TTM cash flow from financing activities is $192.93 M
What is Lexeo Therapeutics TTM CFF year-on-year change?
Over the past year, LXEO TTM cash flow from financing activities has changed by +$185.22 M (+4979.14%)